Bank Hapoalim BM Sells 1,275 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Bank Hapoalim BM trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 42.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,743 shares of the healthcare conglomerate’s stock after selling 1,275 shares during the period. Bank Hapoalim BM’s holdings in UnitedHealth Group were worth $882,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. E. Ohman J or Asset Management AB increased its stake in UnitedHealth Group by 12.3% during the fourth quarter. E. Ohman J or Asset Management AB now owns 41,970 shares of the healthcare conglomerate’s stock valued at $21,231,000 after acquiring an additional 4,590 shares during the period. Mather Group LLC. grew its stake in shares of UnitedHealth Group by 3.9% in the 4th quarter. Mather Group LLC. now owns 5,319 shares of the healthcare conglomerate’s stock valued at $2,691,000 after purchasing an additional 198 shares during the period. Commonwealth Financial Services LLC grew its stake in shares of UnitedHealth Group by 26.3% in the 4th quarter. Commonwealth Financial Services LLC now owns 1,004 shares of the healthcare conglomerate’s stock valued at $508,000 after purchasing an additional 209 shares during the period. Rockline Wealth Management LLC grew its stake in shares of UnitedHealth Group by 1.6% in the 4th quarter. Rockline Wealth Management LLC now owns 12,305 shares of the healthcare conglomerate’s stock valued at $6,225,000 after purchasing an additional 192 shares during the period. Finally, Cullinan Associates Inc. grew its stake in shares of UnitedHealth Group by 5.4% in the 4th quarter. Cullinan Associates Inc. now owns 18,498 shares of the healthcare conglomerate’s stock valued at $9,357,000 after purchasing an additional 950 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Company insiders own 0.33% of the company’s stock.

Analysts Set New Price Targets

UNH has been the topic of several analyst reports. Deutsche Bank Aktiengesellschaft upped their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. UBS Group reduced their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Royal Bank of Canada reduced their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a report on Wednesday, October 16th. Truist Financial reduced their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Finally, KeyCorp reaffirmed an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. One research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Price Performance

UNH stock opened at $545.08 on Wednesday. The stock has a 50-day moving average price of $535.03 and a two-hundred day moving average price of $565.09. The stock has a market cap of $501.63 billion, a PE ratio of 35.17, a price-to-earnings-growth ratio of 1.48 and a beta of 0.61. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company’s revenue was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $5.83 EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.63 EPS for the current fiscal year.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.